Royce & Associates’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-59,009
Closed -$476K 901
2024
Q3
$476K Hold
59,009
﹤0.01% 803
2024
Q2
$500K Hold
59,009
﹤0.01% 787
2024
Q1
$529K Hold
59,009
﹤0.01% 788
2023
Q4
$663K Hold
59,009
0.01% 773
2023
Q3
$509K Hold
59,009
0.01% 811
2023
Q2
$611K Hold
59,009
0.01% 813
2023
Q1
$640K Hold
59,009
0.01% 819
2022
Q4
$662K Hold
59,009
0.01% 798
2022
Q3
$598K Hold
59,009
0.01% 798
2022
Q2
$535K Hold
59,009
0.01% 827
2022
Q1
$564K Hold
59,009
﹤0.01% 869
2021
Q4
$652K Hold
59,009
﹤0.01% 857
2021
Q3
$437K Hold
59,009
﹤0.01% 916
2021
Q2
$857K Hold
59,009
0.01% 866
2021
Q1
$1.2M Hold
59,009
0.01% 830
2020
Q4
$1.05M Sell
59,009
-34,291
-37% -$610K 0.01% 809
2020
Q3
$1.38M Hold
93,300
0.01% 737
2020
Q2
$1.96M Hold
93,300
0.02% 670
2020
Q1
$2.16M Hold
93,300
0.03% 574
2019
Q4
$2.42M Hold
93,300
0.02% 664
2019
Q3
$1.82M Hold
93,300
0.02% 721
2019
Q2
$1.52M Hold
93,300
0.01% 774
2019
Q1
$2.12M Hold
93,300
0.02% 732
2018
Q4
$2.39M Hold
93,300
0.02% 678
2018
Q3
$3.05M Hold
93,300
0.02% 723
2018
Q2
$2.12M Hold
93,300
0.01% 826
2018
Q1
$2.26M Hold
93,300
0.02% 815
2017
Q4
$2.6M Hold
93,300
0.02% 781
2017
Q3
$3.2M Hold
93,300
0.02% 719
2017
Q2
$3.72M Sell
93,300
-10,000
-10% -$398K 0.02% 683
2017
Q1
$3.8M Hold
103,300
0.02% 673
2016
Q4
$3.29M Sell
103,300
-15,500
-13% -$494K 0.02% 691
2016
Q3
$4.31M Sell
118,800
-146,900
-55% -$5.32M 0.03% 640
2016
Q2
$6.03M Sell
265,700
-97,000
-27% -$2.2M 0.04% 534
2016
Q1
$6.82M Sell
362,700
-45,900
-11% -$863K 0.04% 510
2015
Q4
$6.7M Sell
408,600
-105,100
-20% -$1.72M 0.04% 535
2015
Q3
$5.65M Buy
513,700
+27,000
+6% +$297K 0.03% 613
2015
Q2
$6.34M Sell
486,700
-19,200
-4% -$250K 0.03% 670
2015
Q1
$8.78M Sell
505,900
-68,500
-12% -$1.19M 0.03% 622
2014
Q4
$8.57M Buy
574,400
+479,400
+505% +$7.15M 0.03% 649
2014
Q3
$2.19M Sell
95,000
-6,228
-6% -$144K 0.01% 990
2014
Q2
$3.23M Buy
+101,228
New +$3.23M 0.01% 952